SCHEMBL29873554

SCHEMBL29873554

CC(C)(C)OC(=O)NCC(=O)c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CTNNB1 P35222 2/20 0.43
WNT3A P56704 2/20 0.43
GRM4 Q14833 1/20 0.43
BCHE P06276 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
ACACB O00763 1/20 0.42
ACACA Q13085 1/20 0.42
STING1 Q86WV6 1/20 0.42
CKS1B P61024 2/20 0.42
SKP1 P63208 2/20 0.42
SKP2 Q13309 2/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TP53 P04637 1/20 0.42
KMT2A Q03164 1/20 0.41
KDM4A O75164 1/20 0.41
LMNA P02545 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16215497 1.00 ALDH1A1 (0.44) ALDH1A1CTNNB1WNT3AGRM4BCHE
SCHEMBL38663029 0.88 GRM4 (0.45) ALDH1A1CTNNB1WNT3AGRM4BCHE
SCHEMBL20524454 0.85 SMN1; SMN2 (0.50) ALDH1A1CTNNB1WNT3AGRM4SMN1; SMN2
SCHEMBL39993 0.83 CYP3A4 (0.52) ALDH1A1CTNNB1WNT3ABCHESMN1; SMN2
SCHEMBL23367549 0.82 GRM4 (0.46) ALDH1A1CTNNB1WNT3AGRM4SMN1; SMN2
SCHEMBL8278047 0.82 KMT2A (0.61) ALDH1A1SMN1; SMN2KMT2A
SCHEMBL24927890 0.82 P2RX7 (0.45) BCHESTING1CKS1BSKP1SKP2
SCHEMBL29979806 0.82 P2RX7 (0.45) BCHESTING1CKS1BSKP1SKP2
SCHEMBL20524443 0.81 SMN1; SMN2 (0.48) ALDH1A1CTNNB1WNT3AGRM4SMN1; SMN2
SCHEMBL5158131 0.81 SMN1; SMN2 (0.48) ALDH1A1CTNNB1WNT3AGRM4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-B1 HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AG (DE) 2024-05-29 EP disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed
EP-4058446-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 ALDH1A1 2009/4885CTNNB1 2380/4885WNT3A 1960/4885
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 ALDH1A1 3828/4885CTNNB1 3799/4885WNT3A 2007/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ALDH1A1 3828/4885CTNNB1 3799/4885WNT3A 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.